Mar 26, 2024
SPECIAL EDITION
Jonathan Hudson is a Global Trial Leader in Pulmonary Hypertension
at Janssen Research & Development and is accompanied by
colleague Josephine Garcia-Ferrer, Ph.D and Medical Manager.
Jonathan and Josephine discuss Pulmonary Arterial Hypertension
(PAH), the importance of clinical trials, what
they...
Mar 25, 2024
SPECIAL EDITION: Jonathan Hudson is a Global Trial Leader in Pulmonary Hypertension at Janssen Research & Development and is accompanied by colleague Josephine Garcia-Ferrer, Ph.D and Medical Manager.
Jonathan and Josephine discuss Pulmonary Arterial Hypertension (PAH), the importance of clinical trials, what...
Mar 19, 2024
Dr. Lewis Romer discusses his work on the PPHNet's Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric PAH patients.
The Kids Mod PAH study is a research project funded by the NIH that aims to determine the best initial therapy for children with newly diagnosed pulmonary hypertension. The study compares...
Mar 18, 2024
Dr. Lewis Romer discusses his work on the PPHNet's Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric PAH patients.
The Kids Mod PAH study is a research project funded by the NIH that aims to determine the best initial therapy for children with newly diagnosed pulmonary hypertension. The study compares...
Mar 12, 2024
In this episode, Dr. Morris Salem, a pediatric cardiologist, discusses his involvement with Camp del Corazon, a camp for children with congenital heart disease. Dr. Salem emphasizes the importance of addressing the emotional well-being of these patients, in addition to their physical health. He believes that the camp...